- Home
- LEGN vs MASI Comparison
LEGN vs MASI Comparison
Compare LEGN & MASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEGN
- MASI
- Stock Information
- Founded
- LEGN 2014
- MASI 1989
- Country
- LEGN United States
- MASI United States
- Employees
- LEGN N/A
- MASI N/A
- Industry
- LEGN Biotechnology: Pharmaceutical Preparations
- MASI Medical/Dental Instruments
- Sector
- LEGN Health Care
- MASI Health Care
- Exchange
- LEGN Nasdaq
- MASI Nasdaq
- Market Cap
- LEGN 7.0B
- MASI 8.2B
- IPO Year
- LEGN 2020
- MASI 2007
- Fundamental
- Price
- LEGN $27.78
- MASI $155.62
- Analyst Decision
- LEGN Strong Buy
- MASI Buy
- Analyst Count
- LEGN 13
- MASI 6
- Target Price
- LEGN $75.67
- MASI $187.00
- AVG Volume (30 Days)
- LEGN 1.5M
- MASI 650.0K
- Earning Date
- LEGN 05-13-2025
- MASI 05-06-2025
- Dividend Yield
- LEGN N/A
- MASI N/A
- EPS Growth
- LEGN N/A
- MASI N/A
- EPS
- LEGN N/A
- MASI N/A
- Revenue
- LEGN $728,303,000.00
- MASI $2,126,800,000.00
- Revenue This Year
- LEGN $65.96
- MASI N/A
- Revenue Next Year
- LEGN $52.55
- MASI $7.74
- P/E Ratio
- LEGN N/A
- MASI N/A
- Revenue Growth
- LEGN 112.46
- MASI 16.68
- 52 Week Low
- LEGN $29.27
- MASI $101.61
- 52 Week High
- LEGN $60.87
- MASI $194.88
- Technical
- Relative Strength Index (RSI)
- LEGN 29.61
- MASI 46.76
- Support Level
- LEGN $30.25
- MASI $151.13
- Resistance Level
- LEGN $33.30
- MASI $165.28
- Average True Range (ATR)
- LEGN 1.78
- MASI 5.14
- MACD
- LEGN -0.57
- MASI -0.26
- Stochastic Oscillator
- LEGN 5.19
- MASI 49.65
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
About MASI Masimo Corporation
Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.